CN Innovations is a venture capital fund specializing in Series B investments in Health Tech and Biotech companies. A part of the Chung Nam Group, which has operated since 1935 and employs over 11,000 people globally, CN Innovations focuses on areas like medical equipment, automotive, and mobile devices. They have invested in companies such as CN Bio and aim to support firms addressing evolving needs in health and biotechnology sectors.
